Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1 1

Status

Recruiting 13Completed 13Withdrawn 4Not yet recruiting 4Unknown 2Terminated 2Enrolling by invitation 2Available 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1

Conditions

Breast Neoplasms 438Neoplasms 322Carcinoma, Non-Small-Cell Lung 250Prostatic Neoplasms 240Lung Neoplasms 176Colorectal Neoplasms 158Pancreatic Neoplasms 148Neoplasm Metastasis 142Leukemia, Myeloid, Acute 140Multiple Myeloma 131Lymphoma 128Carcinoma, Hepatocellular 127Ovarian Neoplasms 109Melanoma 109Head and Neck Neoplasms 101Brain Neoplasms 101Recurrence 100Leukemia 97Leukemia, Lymphocytic, Chronic, B-Cell 96Precursor Cell Lymphoblastic Leukemia-Lymphoma 90Glioblastoma 85Lymphoma, Non-Hodgkin 83Colonic Neoplasms 79Squamous Cell Carcinoma of Head and Neck 76Lymphoma, Follicular 76Carcinoma, Renal Cell 75Lymphoma, Large B-Cell, Diffuse 71Hematologic Neoplasms 69Sarcoma 60Stomach Neoplasms 58

Interventions

ebselen 1Saline Solution 1Ringer's Lactate 1Ofloxacin 1Ear Protective Devices 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Withdrawn × Hearing Loss × Clear all
NCT01451853 2026-06-03

SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss

Sound Pharmaceuticals, Incorporated

Phase 2 Withdrawn
Head & NeckThoracic

Ototoxicity, Deafness, Head and Neck Neoplasms, Lung Neoplasms, Tinnitus, Hearing Loss

NCT04609982 2024-08-21

SSNHL in Head & Neck Cancer Patients

Nova Scotia Health Authority

Phase NA Withdrawn

Hearing Loss

NCT02778295 2023-02-13

BioFabry

CENTOGENE GmbH Rostock

Withdrawn

Angiokeratoma, Fabry Disease, Hearing Loss, Renal Insufficiency, Chronic

NCT00584155 2015-05-27

Protection From Cisplatin Ototoxicity by Lactated Ringers

University of Oklahoma

Phase 1 Withdrawn

Ear Neoplasms, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡